MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--May 9, 2006--SpinalMotion, developer of investigational artificial discs for treating patients with degenerative disc disease (DDD), today reported that it continues to make significant progress on two United States (U.S.)-based Investigational Device Exemption (IDE) clinical trials for the Kineflex(TM) lumbar disc and Kineflex/C(TM) cervical disc implants. Nearly 400 patients are enrolled in the studies; more than half the required number of patients. Since October 2002, approximately 1,400 Kineflex lumbar and cervical discs have been implanted worldwide.
